PUBLISHER: BCC Research | PRODUCT CODE: 1416214
PUBLISHER: BCC Research | PRODUCT CODE: 1416214
The global market for vaccine technologies is expected to grow from $45.0 billion in 2023 to $65.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.8% from 2023 to 2028.
The global market for subunit, recombinant, polysaccharide, and conjugate vaccines is expected to grow from $23.5 billion in 2023 to $34.4 billion by 2028, at a CAGR of 7.9% from 2023 to 2028.
The global market for live-attenuated vaccines is expected to grow from $8.4 billion in 2023 to $12.1 billion by 2028, at a CAGR of 7.6% from 2023 to 2028.
This report explains critical trends in the vaccine industry. It discusses the market determinants, which act as motivating or restraining factors and provides insights to stakeholders and potential entrants.
This report includes only human vaccines; animal vaccines have not been considered in this report.
This study looks at research and development (R&D) spending, increasing competition and new technologies, which are giving direction to the market. These advancements, new product launches and changing lifestyles are influencing future market growth.
Company mergers, acquisition strategies and collaborations are also covered in this report. Additionally, this study discusses the strengths and weaknesses of each strategy type, considering new technologies, growing competition and changing customer needs.
The market has been analyzed based on the application of current vaccines. Categories considered in this report include pneumococcal vaccines; diphtheria, tetanus vaccines; HPV vaccines; MMR vaccines; and other vaccines including rotavirus vaccines, influenza vaccines, hepatitis B vaccines, chickenpox vaccines, polio vaccines, BCG, and yellow fever vaccines.
This study details market growth among vaccine manufacturers and end users. Genomic research centers, academic institutions, government and private laboratories, various hospital settings, and pharmaceutical, diagnostic and biotechnology companies and physicians will find this study to be of interest.
This report provides useful information to all market players, potential entrants, government agencies and other interested parties. As the report covers geographic regions in detail, companies interested in expanding geographic reach will also find this study useful.